5/18/2015, 1:34 PM (Source: TeleTrader)
more TeleTrader news
Endo International Plc released today they will definitely buy Par Pharmaceutical Holdings Inc. for $8.05 billion, with 18 million shares valued at $1.55 billion and $6.5 billion in cash,including Par's debt. The takeover is expected to end in the second half of this year.

"Our generics business, Qualitest, continues to be an extremely attractive and effective growth driver for Endo. This transaction with Par builds upon our generics growth, adding a strong portfolio of high barrier-to-entry and attractive gross margin products while also transforming Endo, creating a powerful corporate platform for future growth and strategic M&A," said Rajiv De Silva, President and CEO of Endo.

Baha Breaking News (BBN) / NP